Civic Intelligence

AIDS Treatment Activists Coalition

990EZ • Fiscal year 2019 • EIN 57-1168208

Jan 01, 2019 to Dec 31, 2019 • Filed on Nov 04, 2020

Organization Profilewww.aidstreatmentactivists.org
PO Box 9153Denver, CO 80209

(303) 777-5737

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2019

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2019

Net Margin

78th percentile

22%

Higher net margin than 78% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Top Officer Pay

77th percentile

$0

Higher top officer pay than 77% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2019 filings • 501(c)3 • <$500k nonprofits • Source year 2019

Asset Growth

54th percentile

4.7%

Faster asset growth than 54% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Revenue Growth

85th percentile

48%

Faster revenue growth than 85% of similar nonprofits.

2019 filings • 501(c)3 • <$500k nonprofits • Annualized from 2018 to 2019

Balance Sheet
Liabilities / AssetsScore unavailable

Assets

Up

$270,484

Up $12,067 (+4.7%) from 2018

Net Assets

Up

$270,484

Up $12,067 (+4.7%) from 2018

Liabilities

-

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / RevenueScore unavailableNet Margin78th percentile

Revenue

Up

$54,205

Up $17,562 (+48%) from 2018

Expenses

Up

$42,138

Up $7,780 (+23%) from 2018

Net Income

Up

$12,067

Up $9,782 (+428%) from 2018

Historical Trend

Balance Sheet Trend

Asset Growth54th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2010: $122,774Liabilities 2010: $3,159Net Assets 2010: $119,6152010Assets 2011: $164,391Liabilities 2011: $11,9462011Assets 2012: $185,924Liabilities 2012: $02012Assets 2013: $231,480Net Assets 2013: $231,4802013Assets 2014: $240,321Net Assets 2014: $240,3212014Assets 2015: $245,146Net Assets 2015: $245,1462015Assets 2016: $267,141Net Assets 2016: $267,1412016Assets 2017: $256,132Net Assets 2017: $256,1322017Assets 2018: $258,417Net Assets 2018: $258,4172018Assets 2019: $270,484Net Assets 2019: $270,4842019Assets 2020: $249,710Net Assets 2020: $249,7102020Assets 2021: $235,441Net Assets 2021: $235,4412021

Highlighted filing

2019

Assets$270,484
Liabilities-
Net Assets$270,484
Open 2019 Filing

Operations Trend

Revenue Growth85th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$150K$100K$50K$0-$50KRevenue 2010: $86,571Expenses 2010: $115,714Net Income 2010: -$29,1432010Revenue 2011: $98,828Expenses 2011: $65,998Net Income 2011: $32,8302011Revenue 2012: $61,379Expenses 2012: $27,900Net Income 2012: $33,4792012Revenue 2013: $86,547Expenses 2013: $40,991Net Income 2013: $45,5562013Revenue 2014: $38,327Expenses 2014: $29,486Net Income 2014: $8,8412014Revenue 2015: $46,413Expenses 2015: $41,588Net Income 2015: $4,8252015Revenue 2016: $37,707Expenses 2016: $15,712Net Income 2016: $21,9952016Revenue 2017: $36,304Expenses 2017: $47,313Net Income 2017: -$11,0092017Revenue 2018: $36,643Expenses 2018: $34,358Net Income 2018: $2,2852018Revenue 2019: $54,205Expenses 2019: $42,138Net Income 2019: $12,0672019Revenue 2020: $18,142Expenses 2020: $38,916Net Income 2020: -$20,7742020Revenue 2021: $219Expenses 2021: $14,488Net Income 2021: -$14,2692021

Highlighted filing

2019

Revenue$54,205
Expenses$42,138
Net Income$12,067
Open 2019 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2019 to Dec 31, 2019
Signed
Nov 4, 2020
Return Version
2019v5.0
Gross Receipts
$54,205
Mission and Program Overview

Mission

The AIDS Treatment Activists Coalition (ATAC) is a national coalition of AIDS activists, many living with HIV/AIDS, working together to end the AIDS epidemic by advancing research on HIV/AIDS.

Program Services

DescriptionGrantsExpenses
Drug Development Committee (DDC):The Drug Development Committee is ATAC's principal committee. The DDC works with government, academia and industry to expedite and promote ethical HIV research. During 2019, the DDC engaged with every major HIV pharmaceutical company, including Merck & Co, Theratechnologies, Gilead Sciences, VIIV Healthcare, and Janssen Pharmaceuticals.The topics of these conferences included the following:- New drugs in the pipeline with better efficacy, safety profiles and ease of administration.- Continuing safety and efficacy updates on approved drugs, including the status of post-marketing studies .- The design of clinical trials for both nave and heavily pre-treated HIV patients. - The necessity for inclusion of women, people of color and other underrepresented people in clinical trials and the necessity of conducting specific drug-drug interaction studies with new compounds to ensure underrepresented people will be eligible for trials and can participate safely; for example, interaction trials with hormonal contraceptives and methadone.- The need for collaboration among HIV drug companies so that fixed dosed combinations of the best drug cocktails will be available to people with HIV/AIDS- Expanded Access programs to make promising new drugs available to the multi-drug resistant patients that need new drugs the most.- New drugs in the pipeline for Hepatitis C (HCV), especially for individuals co-infected with HCV and HIV.- New strategies and therapies for eradicating HIV viral reservoirs, potentially leading to either a virtual cure or a sterilizing cure.Collaborations:The DDC continued working with other national and international AIDS advocacy groups, collaborating with the Treatment Action Group and Project Inform on HIV "Cure" Research and also with our European counterpart, the European Community Advisory Board (ECAB), part of the European AIDS Treatment Group. DDC members continue to participate with ECAB/EATG members in meetings with HIV drug companies. In addition, ATAC continues to build a collaborative relationship with the Martin Delaney Cure Collaboratories at various academic institutions across the United States.$38,837-
Compensation and Service Providers
Top Officer Pay77th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
MOISES AGOSTODirector-$0--
MURRAY PENNERPresident-$0--
MATTHEW ROSEDirector-$0--
DAVID PALMSecretary-$0--
MICHAEL DOROSHDirector-$0--
ROBERT HUFFDirector-$0--
ANDREW KAYTESTreasurer-$0--
DANIELLE CAMPBELLDirector-$0--
FRED SCHAICHDirector-$0--
RICHARD GUASCODirector-$0--
Filing and Contact Details

Filer

Filer Name
Aids Treatment Activists Coalition
EIN
57-1168208
Phone
3037775737
Address
PO BOX 9153, DENVER, CO 80209

Signing Officer

Name
Michael Dorosh
Title
Director
Signed
2020-11-04
Discuss with paid preparer
Yes

Preparer

Firm
Dinowitz & Bove CPAs
Address
150 Broadway Ste 1010, New York, NY 10038
Preparer
Frank Bove
Phone
2129730935
Supplemental Narrative

Additional Explanations

Other Expenses.1003

“Information Technology $231”

Other Expenses.1005

“Travel $14653”

Other Expenses.1007

“Conferences, Conventions, and Meetings $5439”

Other Expenses.1012

“Insurance $1340”

Other Expenses.1

“Lodging $13702”

Other Expenses.2

“Meals $4094”

Other Expenses.3

“Fees $583”

Other Expenses.5

“Telephone $272”

Raw XML Appendix185 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0MICHAEL DOROSH
IRS990EZ/BooksInCareOfDetail/PhoneNum03037775737
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt038 W MAPLE AVENUE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0DENVER
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CO
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd080223
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0258417
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0270484
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt054000
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt012067
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01491
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0258417
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0270484
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt054205
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt0205
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0258417
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0270484
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0258417
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0270484
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt71.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt81.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt91.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt90
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0MOISES AGOSTO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1MURRAY PENNER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2MATTHEW ROSE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3DAVID PALM
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4MICHAEL DOROSH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5ROBERT HUFF
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6ANDREW KAYTES
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7DANIELLE CAMPBELL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm8FRED SCHAICH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm9RICHARD GUASCO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Secretary
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt8Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt9Director
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt040314
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0The AIDS Treatment Activists Coalition (ATAC) is a national coalition of AIDS activists, many living with HIV/AIDS, working together to end the AIDS epidemic by advancing research on HIV/AIDS.
IRS990EZ/PrintingPublicationsPostageAmt0333
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Drug Development Committee (DDC):The Drug Development Committee is ATAC's principal committee. The DDC works with government, academia and industry to expedite and promote ethical HIV research. During 2019, the DDC engaged with every major HIV pharmaceutical company, including Merck & Co, Theratechnologies, Gilead Sciences, VIIV Healthcare, and Janssen Pharmaceuticals.The topics of these conferences included the following:- New drugs in the pipeline with better efficacy, safety profiles and ease of administration.- Continuing safety and efficacy updates on approved drugs, including the status of post-marketing studies .- The design of clinical trials for both nave and heavily pre-treated HIV patients. - The necessity for inclusion of women, people of color and other underrepresented people in clinical trials and the necessity of conducting specific drug-drug interaction studies with new compounds to ensure underrepresented people will be eligible for trials and can participate safely; for example, interaction trials with hormonal contraceptives and methadone.- The need for collaboration among HIV drug companies so that fixed dosed combinations of the best drug cocktails will be available to people with HIV/AIDS- Expanded Access programs to make promising new drugs available to the multi-drug resistant patients that need new drugs the most.- New drugs in the pipeline for Hepatitis C (HCV), especially for individuals co-infected with HCV and HIV.- New strategies and therapies for eradicating HIV viral reservoirs, potentially leading to either a virtual cure or a sterilizing cure.Collaborations:The DDC continued working with other national and international AIDS advocacy groups, collaborating with the Treatment Action Group and Project Inform on HIV "Cure" Research and also with our European counterpart, the European Community Advisory Board (ECAB), part of the European AIDS Treatment Group. DDC members continue to participate with ECAB/EATG members in meetings with HIV drug companies. In addition, ATAC continues to build a collaborative relationship with the Martin Delaney Cure Collaboratories at various academic institutions across the United States.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt038837
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NY
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt042138
IRS990EZ/TotalProgramServiceExpensesAmt038837
IRS990EZ/TotalRevenueAmt054205
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/WebsiteAddressTxt0www.aidstreatmentactivists.org
IRS990ScheduleA/FactsAndCircumstancesTestTxt0Prior Year Facts and Circumstances: The Organization will be maintaining a continuous and bona fide program for solicitation of funds from the general public involved.
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt054000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt036040
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt036100
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt037500
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt046154
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0209794
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0205
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0603
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0204
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0207
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0259
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01478
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.19600
IRS990ScheduleA/PublicSupportPY170Pct00.21410
IRS990ScheduleA/PublicSupportTotal170Amt041419
IRS990ScheduleA/SubstantialContributorsTotAmt0168375
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/TenPctFactsCrcmstncsTestCYInd0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt054000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt036040
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt036100
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt037500
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt046154
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0209794
IRS990ScheduleA/TotalSupportAmt0211272
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Information Technology $231
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Travel $14653
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Conferences, Conventions, and Meetings $5439
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Insurance $1340
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Lodging $13702
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5Meals $4094
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6Fees $583
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7Telephone $272
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1003
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.1005
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1007
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.1012
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Other Expenses.5
ReturnHeader/BuildTS02021-01-29 14:40:06Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0MICHAEL DOROSH
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Director
ReturnHeader/BusinessOfficerGrp/SignatureDt02020-11-04
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0AIDS TREATMENT ACTIVISTS COALITION
ReturnHeader/Filer/BusinessNameControlTxt0AIDS
ReturnHeader/Filer/EIN0571168208
ReturnHeader/Filer/PhoneNum03037775737
ReturnHeader/Filer/USAddress/AddressLine1Txt0PO BOX 9153
ReturnHeader/Filer/USAddress/CityNm0DENVER
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CO
ReturnHeader/Filer/USAddress/ZIPCd080209
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0020632187
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Dinowitz & Bove CPAs
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0150 Broadway Ste 1010
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0New York
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd010038
ReturnHeader/PreparerPersonGrp/PhoneNum02129730935
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0FRANK BOVE
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02020-11-04T14:12:38-08:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02019-01-01
ReturnHeader/TaxPeriodEndDt02019-12-31
ReturnHeader/TaxYr02019

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2019 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$270,484
Liabilities
-
Net assets
$270,484
Revenue
$54,205
Expenses
$42,138
Net income
$12,067
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2021Detailed filing. Detailed filing data is available for this year.$2.35$2.35$0.00$0.14$0.14
2020Detailed filing. Detailed filing data is available for this year.$2.50$2.50$0.18$0.39$0.21
2019Detailed filing. Detailed filing data is available for this year.$2.70$2.70$0.54$0.42$0.12
2018Detailed filing. Detailed filing data is available for this year.$2.58$2.58$0.37$0.34$0.02
2017Detailed filing. Detailed filing data is available for this year.$2.56$2.56$0.36$0.47$0.11
2016Detailed filing. Detailed filing data is available for this year.$2.67$2.67$0.38$0.16$0.22
2015Detailed filing. Detailed filing data is available for this year.$2.45$2.45$0.46$0.42$0.05
2014Detailed filing. Detailed filing data is available for this year.$2.40$2.40$0.38$0.29$0.09
2013Detailed filing. Detailed filing data is available for this year.$2.31$2.31$0.87$0.41$0.46
2012Summary only. Only limited summary data is available for this year.$1.86$0.00$0.61$0.28$0.33
2011Summary only. Only limited summary data is available for this year.$1.64$0.12$0.99$0.66$0.33
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.23$0.03$1.20$0.87$1.16$0.29